Acrivon Therapeutics, Inc.

ACRV · XNAS

CIK 1781174fmd_13P7S5H4SVRTEFPYKMZEMAFA98Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2021 to Jun 30, 2026, 22 periods

Ratios computed from the standardized statements. Select a value to open its proof.